Abstract
OBJECTIVE: To evaluate the long term health consequences of past occupational exposure to 2,3,7,8 tetrachlorodibenzo-p-dioxin (TCDD). METHODS: Cancer incidence and cause specific mortality were examined up to and including 1992 in a group of 243 men with external comparisons and internal dose-response analyses. Model based estimates of TCDD dose (expressed in micrograms/kg body weight) were developed for all cohort members with an approach that incorporated detailed accounts of each employee's work activities, analyses of TCDD in blood lipid of 138 employees, and internally derived estimates of elimination rates of TCDD. RESULTS: The estimated dose of TCDD for 135 men was > or = 0.1 microgram/kg body weight and for 69 men > or = 1 microgram/kg body weight. Increased cancer risk ratios were found with higher doses of TCDD and longer interval since first exposure for all sites combined and digestive and respiratory cancers in particular. Within the high dose group (> or = 1 microgram/kg body weight), total cancer mortality was increased > or = 20 years after first exposure (13 cases, standardised mortality ratio (SMR) 1.97, 95% confidence interval (95% CI) 1.05-3.36) as was respiratory cancer (six cases, SMR 3.06; 95% CI 1.12-6.66). Among current cigarette smokers, 12 cancer deaths occurred in the high dose group (SMR 3.42, 95% CI 1.77-5.97) compared with seven deaths at lower doses of TCDD (SMR 1.29, 95% CI 0.52-2.66). Regression analyses based on the Cox's proportional hazards model provided further evidence of a relation between cumulative dose of TCDD and occurrence of both overall and digestive cancer. No evidence of an effect of TCDD on overall mortality or deaths due to circulatory disease was found and no cases of non-Hodgkin's lymphoma or soft tissue sarcoma have been found to date. CONCLUSIONS: Our findings are consistent with a carcinogenic effect induced by TCDD at doses > or = 1 microgram/kg body weight. With such a small cohort, the risk estimates are not very stable and could be affected by selection and confounding.
Full text
PDF






Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Beebe L. E., Anver M. R., Riggs C. W., Fornwald L. W., Anderson L. M. Promotion of N-nitrosodimethylamine-initiated mouse lung tumors following single or multiple low dose exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Carcinogenesis. 1995 Jun;16(6):1345–1349. doi: 10.1093/carcin/16.6.1345. [DOI] [PubMed] [Google Scholar]
- Birnbaum L. S. The mechanism of dioxin toxicity: relationship to risk assessment. Environ Health Perspect. 1994 Nov;102 (Suppl 9):157–167. doi: 10.1289/ehp.94102s9157. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Geyer H. J., Scheuntert I., Rapp K., Kettrup A., Korte F., Greim H., Rozman K. Correlation between acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and total body fat content in mammals. Toxicology. 1990 Dec 17;65(1-2):97–107. doi: 10.1016/0300-483x(90)90081-q. [DOI] [PubMed] [Google Scholar]
- Hill I. D. Computing man years at risk. Br J Prev Soc Med. 1972 May;26(2):132–134. doi: 10.1136/jech.26.2.132. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lee I. M., Manson J. E., Hennekens C. H., Paffenbarger R. S., Jr Body weight and mortality. A 27-year follow-up of middle-aged men. JAMA. 1993 Dec 15;270(23):2823–2828. doi: 10.1001/jama.270.23.2823. [DOI] [PubMed] [Google Scholar]
- Mably T. A., Theobald H. M., Ingall G. B., Peterson R. E. Hypergastrinemia is associated with decreased gastric acid secretion in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated rats. Toxicol Appl Pharmacol. 1990 Dec;106(3):518–528. doi: 10.1016/0041-008x(90)90346-v. [DOI] [PubMed] [Google Scholar]
- Manz A., Berger J., Dwyer J. H., Flesch-Janys D., Nagel S., Waltsgott H. Cancer mortality among workers in chemical plant contaminated with dioxin. Lancet. 1991 Oct 19;338(8773):959–964. doi: 10.1016/0140-6736(91)91835-i. [DOI] [PubMed] [Google Scholar]
- Monson R. R. Analysis of relative survival and proportional mortality. Comput Biomed Res. 1974 Aug;7(4):325–332. doi: 10.1016/0010-4809(74)90010-x. [DOI] [PubMed] [Google Scholar]
- Ott M. G., Messerer P., Zober A. Assessment of past occupational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin using blood lipid analyses. Int Arch Occup Environ Health. 1993;65(1):1–8. doi: 10.1007/BF00586050. [DOI] [PubMed] [Google Scholar]
- Ott M. G., Zober A., Germann C. Laboratory results for selected target organs in 138 individuals occupationally exposed to TCDD. Chemosphere. 1994 Nov-Dec;29(9-11):2423–2437. doi: 10.1016/0045-6535(94)90411-1. [DOI] [PubMed] [Google Scholar]
- Patterson D. G., Jr, Fingerhut M. A., Roberts D. W., Needham L. L., Sweeney M. H., Marlow D. A., Andrews J. S., Jr, Halperin W. E. Levels of polychlorinated dibenzo-p-dioxins and dibenzofurans in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Am J Ind Med. 1989;16(2):135–146. doi: 10.1002/ajim.4700160205. [DOI] [PubMed] [Google Scholar]
- Wolfe W. H., Michalek J. E., Miner J. C., Pirkle J. L., Caudill S. P., Patterson D. G., Jr, Needham L. L. Determinants of TCDD half-life in veterans of operation ranch hand. J Toxicol Environ Health. 1994 Apr;41(4):481–488. doi: 10.1080/15287399409531858. [DOI] [PubMed] [Google Scholar]
- Zober A., Messerer P., Huber P. Thirty-four-year mortality follow-up of BASF employees exposed to 2,3,7,8-TCDD after the 1953 accident. Int Arch Occup Environ Health. 1990;62(2):139–157. doi: 10.1007/BF00383591. [DOI] [PubMed] [Google Scholar]
- Zober A., Ott M. G., Fleig I., Heidemann A. Cytogenetic studies in lymphocytes of workers exposed to 2,3,7,8-TCDD. Int Arch Occup Environ Health. 1993;65(3):157–161. doi: 10.1007/BF00381151. [DOI] [PubMed] [Google Scholar]
- Zober A., Ott M. G., Messerer P. Morbidity follow up study of BASF employees exposed to 2,3,7, 8-tetrachlorodibenzo-p-dioxin (TCDD) after a 1953 chemical reactor incident. Occup Environ Med. 1994 Jul;51(7):479–486. doi: 10.1136/oem.51.7.479. [DOI] [PMC free article] [PubMed] [Google Scholar]